Statistics

Total Visits

Views
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint 102
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint 99

Total Visits per Month

December 2023 January 2024 February 2024 March 2024 April 2024 May 2024 June 2024
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint 2 4 1 1 6 16 0

File Downloads

Views

Top Country Views

Views
United States 55
China 29
France 10
Netherlands 8
Hong Kong SAR China 6
Singapore 6
Australia 5
Vietnam 5
Argentina 3
Brazil 1

Top City Views

Views
Ashburn 18
Beijing 10
Rotterdam 8
Hanoi 5
Singapore 5
Zhengzhou 5
Fairfield 3
Kaleen 3
Des Moines 2
Qingping 2